Nissan Infiniti Recall Issued Due to Risk of Sudden Engine Stall

Nissan Motor Company has announced a recall for roughly 908,307 Infiniti M35 and M45 vehicles from certain model years, due to a risk that the accelerator pedal sensors may deteriorate over time and cause the vehicles to suddenly stall, posing an increased crash hazard.ย  ย 

The Nissan Infiniti recall (PDF) was announced by the National Highway Traffic Safety Administration (NHTSA) on September 26, after multiple complaints were received of slow acceleration and engines stalling when the vehicles were coming to a stop or idling.

Although this may pose a risk that drivers may lose control of their vehicles or cause a rear-end collision, no reports of accidents or injuries have been received to date.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

The accelerator pedals are equipped with a sensor signal that gauges the level of acceleration. Over time this sensor signal may deteriorate and accumulate dust build up that may result in an incorrect sensor output, causing the engine to go into fail-safe mode.

The recall affects 2006 through 2010 Nissan Infiniti M35 and M45 models manufactured between April 4, 2004 and October 5, 2010. The NHTSA campaign number for the recall is 13V-430. Nissan announced that these particular models are the only vehicles manufactured with this accelerator design and that no other vehicles are affected.

The accelerator pedals were manufactured by Aisan Industry Co., LTD, of Aichi, Japan. They were sold to Nissan to be installed in the affected M35 and M45 models.

Nissan plans to notify owners and dealers of the recall in early November where they will begin scheduling repair appointments to replace the accelerator pedal assembly and reprogram the engine control module free of charge. Owners with questions or concerns may contact Nissan at 1-800-647-7261.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.
A Florida womanโ€™s lawsuit alleges that Abbott Laboratories and Boston Scientific altered their SCS device batteries, firmware and stimulation features without adequate safety testing approved by the FDA.
A Depo-Provera lawsuit filed against Pfizer says the manufacturer knew Depo-Provera could stimulate brain tumor growth before the birth control shots hit the market, yet failed to warn doctors and patients.